Replies to post #38568 on Biotech Values

[DewDiligence]

>In the generic area, just wondering if you expect consolidation to continue…<

Absolutely. I will prepare a chart to show why.

>…and if so, who might be next to be acquired?<

Anything that moves!

[DewDiligence]

More Consolidation Is Inevitable in Generics
In the U.S. generic market, there are still many
companies with a tiny market share.



Note: Pliva and Andrx are circled because they were acquired (by Barr and Watson, respectively) since this chart was prepared a few months ago.

[genisi]

FWIW, Some analysts here in Israel like TARO under 10$ and bet it will be bought soon.